Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1
暂无分享,去创建一个
[1] D. Schaid,et al. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[2] Andrew G. Brooks,et al. NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor , 1997, The Journal of experimental medicine.
[3] G. Nepom,et al. CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles. , 1996, Journal of immunology.
[4] L. Lanier,et al. Arousal and inhibition of human NK cells , 1997, Immunological reviews.
[5] W. Yokoyama. Natural killer cell receptors. , 1998, Current opinion in immunology.
[6] C. Weyand,et al. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. , 1996, The Journal of clinical investigation.
[7] M. Carretero,et al. The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules , 1997, European journal of immunology.
[8] P Parham,et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.
[9] A. Vallejo,et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. , 1999, Journal of immunology.
[10] J. Coligan,et al. Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.
[11] R. Bellomo,et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[13] A. Fauci,et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Llano,et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Moretta,et al. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. , 1998, Immunology today.
[16] M. Llano,et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD 94 y NKG 2 A , 1998 .
[17] L. Moretta,et al. HLA class I specific inhibitory receptors. , 1997, Current opinion in immunology.
[18] J. Bell,et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.
[19] Eric O Long,et al. Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.
[20] H. Rittner,et al. Multiple Mechanisms Support Oligoclonal T Cell Expansion in Rheumatoid Synovitis , 1997, Molecular medicine.
[21] R. Biassoni,et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.
[22] B. Dupont,et al. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. , 2008, Tissue antigens.
[23] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[24] W. Seaman,et al. DAP12-mediated Signal Transduction in Natural Killer Cells , 1998, The Journal of Biological Chemistry.
[25] P Parham,et al. Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.
[26] Eric O Long,et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.
[27] O. Mandelboim,et al. The binding site of NK receptors on HLA-C molecules. , 1997, Immunity.
[28] C. Weyand,et al. The Repertoire of CD4+ CD28− T Cells in Rheumatoid Arthritis , 1996, Molecular medicine.
[29] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[30] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[31] J. Hansen,et al. A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. , 1989, Journal of immunology.
[32] P. Carlson,et al. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. , 1996, Arthritis and rheumatism.
[33] C. Weyand,et al. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. , 1994, The Journal of clinical investigation.
[34] C. Weyand,et al. The molecular basis of rheumatoid arthritis , 1997, Journal of Molecular Medicine.
[35] M. Colonna,et al. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.
[36] M. López-Botet,et al. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. , 1996, Journal of immunology.
[37] G. Powis,et al. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. , 1988, Journal of immunology.
[38] P. Parham,et al. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.
[39] S. Balk,et al. Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.
[40] Jun Wu,et al. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.
[41] A. Zettl,et al. T cell receptor repertoire in rheumatoid arthritis. , 1998, International reviews of immunology.
[42] R. Biassoni,et al. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. , 1997, International immunology.
[43] C. Weyand,et al. Co‐stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells , 1997, European journal of immunology.
[44] G. Nepom,et al. Autoreactive T cells from a type I diabetic recognize multiple class II products. , 1993, Human immunology.
[45] W. Seaman,et al. Divergent functions of lectin‐like receptors on NK cells , 1997, Immunological reviews.
[46] U. Wagner,et al. Functional subsets of CD4 T cells in rheumatoid synovitis. , 1998, Arthritis and rheumatism.
[47] O. Mandelboim,et al. Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.